Dados B3 › SEQL3 × VAMO3
SEQL3 × VAMO3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | SEQL3 | VAMO3 | year |
|---|---|---|---|
| ROE | 0.0% | 0.0% | 2023 |
| ROIC | -20.1%! | 13.8% | 2025 |
| ROA | -19.7% | 1.5% | 2025 |
| Gross margin | 6.8% | 52.4% | 2025 |
| EBIT margin | -4.7% | 45.4% | 2025 |
| Net margin | -33.0% | 5.7% | 2025 |
| Net debt/EBITDA | 4.00x | 3.28x | 2025 |
| Current ratio | 0.39x | 1.81x | 2025 |
| Revenue growth (1y) | -22.9% | 22.5% | 2025 |
| Revenue growth (5y CAGR) | -9.9% | 30.6% | 2025 |
| Piotroski F-Score | 7/9 | 5/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | SEQL3 | VAMO3 | year |
|---|---|---|---|
| P/E | -0.04x | — | 2024 × 2025 |
| P/B | — | 1.55x | 2024 × 2025 |
| EV/EBITDA | — | 4.37x | 2024 × 2025 |
| FCF yield | 162.5% | -23.1% | 2024 × 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:12 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:12 UTC. If this does not match /saude, you are reading a cached copy.